Dar Zavain bought RXRX
April 1, 2026 · Form 4 insider transaction
Dar Zavain bought 4,902 shares of Recursion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,902
Price
$0.00
Total value
N/A
InsiderDar Zavain
Role—
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after147,231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.